Health Catalyst, Inc. (HCAT)
| Market Cap | 2.02B |
| Revenue (ttm) | 179.07M |
| Net Income (ttm) | -86.27M |
| Shares Out | 40.29M |
| EPS (ttm) | -28.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 21 |
| Last Price | $48.53 |
| Previous Close | $47.59 |
| Change ($) | 0.94 |
| Change (%) | 1.98% |
| Day's Open | 47.48 |
| Day's Range | 47.01 - 48.92 |
| Day's Volume | 211,487 |
| 52-Week Range | 17.80 - 48.92 |
If you desire growth, then your sights should be set on small-cap stocks. These 11 have attracted the gaze of dozens of Wall Street's best minds.
SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...
SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...
US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage thei...
Health Catalyst (HCAT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
SALT LAKE CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 22.22% over the past year to ($0.21)...
SALT LAKE CITY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today repo...
Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsibilities to Support Continued Growth and Expansion Announces Promotion of Bryan Hunt as CFO and Additional Leadership...
Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SALT LAKE CITY, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...
SALT LAKE CITY, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...
SALT LAKE CITY, Oct. 22, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...
As data is becoming more vital to healthcare, investors should consider buying "big data" stocks with high exposure to the sector. The post 3 Big Data Stocks Making Healthcare Better appeared ...
Yes, it's a leader with lots of momentum. But you need to understand this one key difference.
Health Catalyst - Looks Cheap But Where Is The Catalyst?
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2020 Results - Earnings Call Transcript
Shares of Health Catalyst (NASDAQ:HCAT) fell 8.31% in after-market trading after the company reported Q2 results.
Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare or...
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today re...
SALT LAKE CITY, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...
Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Health Catalyst (HCAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...
SALT LAKE CITY, July 28, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...
As of late, it has definitely been a great time to be an investor in Health Catalyst.
SALT LAKE CITY, July 09, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare or...
Big data is becoming a big factor in the healthcare industry.
Health Catalyst reported the results of its fiscal Q1 (ended 3/31) last week.
Health Catalyst - Helping Health Care Providers Manage Through The Covid-19 Crisis
Medical Info Systems Outlook Bright Amid Coronavirus Crisis
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2020 Results - Earnings Call Transcript
SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today rep...
SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- The board of directors (the “Board”) of Health Catalyst, Inc. ("Health Catalyst,” Nasdaq: HCAT ), a leading provider of data and analytics...
Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Despite the negative earnings trend, a handful of stocks with a favorable Zacks Rank are poised to beat earnings estimates this week.
Health Catalyst Prepares For Pandemic Sales Slowdown
These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.
SALT LAKE CITY, April 09, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal...
SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market condi...
Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.
Health Catalyst (HCAT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Health Catalyst, Inc. (HCAT) CEO Daniel Burton on Q4 2019 Results - Earnings Call Transcript
SALT LAKE CITY, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...
As of late, it has definitely been a great time to be an investor Health Catalyst.
About HCAT
Health Catalyst provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.
| Industry Health Information Services | IPO Date Jul 25, 2019 |
| CEO Daniel D. Burton | Employees 1,000 |
| Stock Exchange NASDAQ | Ticker Symbol HCAT |
Financial Performance
In 2019, HCAT's revenue was $154.94 million, an increase of 37.63% compared to the previous year's $112.57 million. Losses were -$60.10 million, -3.05% less than in 2018.
Analyst Forecasts
According to 14 analysts, the average rating for HCAT stock is "Strong Buy." The 12-month stock price forecast is 44.85, which is a decrease of -7.58% from the latest price.